Day One Biopharmaceuticals, Inc.
DAWN
$9.73
$0.748.23%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -151.76M | -95.00M | -69.08M | -95.50M | -84.29M |
| Total Depreciation and Amortization | 3.55M | 3.36M | 2.81M | 2.03M | 1.37M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 29.08M | 88.82M | -13.87M | -11.13M | -10.10M |
| Change in Net Operating Assets | -489.00K | -60.24M | -7.24M | 26.48M | 3.55M |
| Cash from Operations | -119.62M | -63.06M | -87.38M | -78.11M | -89.48M |
| Capital Expenditure | -1.74M | -2.46M | -2.49M | -2.17M | -758.00K |
| Sale of Property, Plant, and Equipment | 32.00K | 32.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -260.76M | -341.20M | -350.41M | -228.83M | 69.78M |
| Cash from Investing | -262.47M | -343.63M | -352.90M | -230.99M | 69.03M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.60M | 181.75M | 182.30M | 182.35M | 181.10M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 20.94M | 20.94M | 20.94M | 20.94M |
| Cash from Financing | 2.60M | 202.69M | 203.24M | 203.29M | 202.04M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -379.49M | -203.99M | -237.03M | -105.82M | 181.59M |